Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Syngene International Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-02-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Despite big fall, most fundamentallystrong stocks still remain expensive

2018-02-05 thehindubusinessline
Priya Kansara If you thought that you could buy your favourite stocks after the carnage on Friday wherein Nifty Midcap and Nifty Smallcap had tanked 4 per cent and 6 per cent, respectively, on a single trading session, then here is the bad news. Most stocks, which lost the most on Black Friday, have not been among analysts’ top picks. So, investors have no choice but to keep a long-term view and buy the good stocks or future likely outperformers at expensive valuation. (13-0)

Syngene International Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-02-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Biocon profit down 46% to Rs91.9 crore in December quarter

2018-01-24 livemint
Mumbai: Biocon Ltd’s consolidated net profit declined 46% to Rs91.9 crore in the quarter ended 31 December as interest and depreciation costs relating to its Malaysia facility rose. The Bengaluru-based company’s net sales rose 1.3% to Rs1,057.9 crore during the quarter from a year earlier.

Closing Bell: Sensex ends flat, Nifty ends above 11,000; SBI up 4%

2018-01-24 moneycontrol
3:30 pm Market at Close: After trading rangebound for a larger part of the day, market has ended the day on a flat note. The Sensex was up 15.75 points at 36155.73, while the Nifty was up 2.30 points at 11086.00. The market breadth favoured the declines as 1005 shares advanced, against a decline of 1895 shares, while 240 shares were unchanged. (36-0)

Syngene Q3 net profit up 11% at Rs 82 crore

2018-01-23 moneycontrol
Biocon's contract research arm Syngene International today posted 10.81 per cent increase in its net profit at Rs 82 crore for the third quarter ended December 2017.

Syngene International Limited - Outcome of Board Meeting

2018-01-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Syngene International Limited - Press Release

2018-01-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Syngene International Limited - Financial Result Updates

2018-01-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Steadview Capital sells 19.50 lakh shares of Syngene International

2017-11-24 moneycontrol
On November 23, 2017 Gaoling Fund LP bought 15,00,000 shares of Syngene International at Rs 515 on the BSE.

Syngene International Limited

2017-11-14 thehindubusinessline
Syngene International has expanded its ongoing drug discovery and development operations with its US-based partner Bristol-Myers Squibb till 2026, the company said in a notice to the stock exchanges. The expansion would also include addition of a new facility and ramping up the team of scientists, the statement added. As part of the expansion, it will set up a new dedicated facility spread across 25,000 sq ft of laboratory and office space for Bristol-Myers Squibb. (72-0)

Biocon arm widens partnership terms with Bristol-Myers Squibb

2017-11-14 thehindubusinessline
Biocon’s contract research arm Syngene International has expanded its ongoing drug discovery and development with US-based Bristol-Myers Squibb till 2026. (72-0)

Biocon arm widens partnership terms with Bristol-Myers Squibb

2017-11-14 moneycontrol
Biocon's contract research arm Syngene International has expanded its ongoing drug discovery and development with US-based Bristol-Myers Squibb till 2026. (72-0)

Syngene International Limited - Press Release

2017-11-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)